Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Therapeutic Strategies for High-Risk Pediatric Sarcomas
NCT00001335Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1993
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in Ewing sarcoma, rhabdomyosarcoma (RMS), neuroblastoma, sponsored by National Cancer Institute. Started Apr 1993; status: completed.
02
Drugs
topotecan
03
Conditions
Ewing sarcomarhabdomyosarcoma (RMS)neuroblastoma
Beyond the preview
Go deeper on NCT00001335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001335.